# Mobile Patient-Reported Outcomes for Value and Effectiveness (mPROVE)

> **NIH AHRQ U18** · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2021 · $398,734

## Abstract

PROJECT SUMMARY/ABSTRACT
 Over half of Americans have at least one chronic disease, which include depression, diabetes, and
hypertension. By definition, chronic diseases are 24/7 and impact all aspects of our patients' lives. It is thus
patients themselves - through self-management of medication, lifestyle, exercise, and nutrition - who have the
greatest potential to improve their disease states. Effective self-management requires timely and actionable
feedback to patients on how their behavior impacts outcomes that are personally meaningful to them. Patient-
reported outcomes (PROs) of symptoms such as depression, anxiety, mood, sleep, and cognitive function are
of interest and meaningful to almost all patients with chronic conditions. When shared with providers, such
PRO information can provide a singular view of the patient's perspective to inform shared decision-making.
 The ubiquitous nature of chronic diseases and the need for 24/7/anywhere data collection and feedback call
for a mobile solution. With over 75% of Americans owning a smartphone, we can now use personal mobile
technologies to collect and view PROs as never before possible. To date, we have secured key institutional
support for a mobile PRO strategy at the University of California San Francisco (UCSF). UCSF's Division of
General Internal Medicine (DGIM) serves a population of 25,000 primary care patients who reflect the ethnic
and cultural diversity of the Bay Area, with over half of patients being racial/ethnic minorities and 21% Asian.
Accordingly, we propose to develop the Mobile Patient-Reported Outcomes for Value and Effectiveness
(mPROVE) system in English, Spanish, and Chinese for patient self-care and shared decision-making
(Aim 1). Patients will use a smartphone app to collect and view PROs such as the PROMIS-29 and the novel
Photographic Affect Meter visual PRO that assesses mood via a set of images. To make the PRO results
seamlessly available to providers within their workflow, we will integrate mPROVE into UCSF's Epic
electronic health record (EHR) and into UCSF's primary care workflow (Aim 2). We will use cutting-edge
SMART-on-FHIR technology to embed PRO results into a window in the patient's EHR encounter without
requiring any login by the provider. After conducting participatory design sessions, field testing, workflow
prototyping, and pilot testing with patients, providers, and clinic staff, we will evaluate mPROVE using a Type
2 hybrid effectiveness-implementation study (Aim 3). Quality of care and implementation outcomes will be
evaluated by a single-arm prospective interventional cohort study of 120 DGIM patients. Main effectiveness
outcomes are PROMIS-29 health-related quality of life, shared decision-making, and self-efficacy. Main
implementation outcomes include rates of PRO collection and PRO dashboard usage.
 mPROVE success will demonstrate a PRO intervention and implementation strategy that serves diverse
populations, can be generalized to non-traditi...

## Key facts

- **NIH application ID:** 10246841
- **Project number:** 5U18HS026883-03
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- **Principal Investigator:** Jane Jih
- **Activity code:** U18 (R01, R21, SBIR, etc.)
- **Funding institute:** AHRQ
- **Fiscal year:** 2021
- **Award amount:** $398,734
- **Award type:** 5
- **Project period:** 2019-09-01 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10246841

## Citation

> US National Institutes of Health, RePORTER application 10246841, Mobile Patient-Reported Outcomes for Value and Effectiveness (mPROVE) (5U18HS026883-03). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10246841. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
